Primary tabs

Search
Limit to
Export 74 results:
Filters: Author is L. Tesolin
2024
Advanced Analysis of Biopharmaceuticals: Endotoxin content & Sterility testing, Tesolin, L. , African Medicines Regulatory Harmonization (AMRH) 5th Continental GMP Training Workshop: A focus on Vaccines and other Biologics 9-12 December, 2024, virtual Webinair, 09/12/2024, virtual, (2024)
The batch release procedure in Europe, Tesolin, L. , Seminaire etudiants en pharmacie ULB, 22/11/2024, ULB Brussels, (2024)
CHIKUNGUNYA VIRUS (LIVE ATTENUATED), Tesolin, L., Bruysters M., Garcia D., Oppling V., Campitelli L., and Pullirsch D. , 01/07/2024, Strasbourg (F), p.15, (2024)
EU Annual report : batch release of human vaccines, Waeterloos, Geneviève, Van Molle Wim, Tesolin L., Ribaucour F, Florens Morgane, Masquelier F., Clouet S., Domicent C., Auquier J., Laurent F., et al. , 01/04/2024, Brussels, Belgium, p.261, (2024)
Guideline for Monovalent or Multivalent Meningococcal Conjugate Vaccine, Tesolin, L., Bruysters M., Campitelli L., Pullirsch D., Oppling V., and Garcia D. , 18/11/2024, 18/11/2024, p.19, (2024)
Guideline for Respiratory Syncytial Virus (mRNA) Vaccine, Tesolin, L., Bruysters M., Campitelli L., Pullirsch D., Oppling V., and Garcia D. , 17/09/2024, Strasbourg (F), p.18, (2024)
Implementing the 3RS in quality Control and batch release testing - view from a Belgian OMCL, Florens, Morgane, and Tesolin L. , AFMPS - Advancing the 3Rs for Regulatory Testing of Medicines-31/01/2024-Antwerpen, Belgium, 31/01/2024, Brussels, Belgium, (2024)
regulatory roadmap for 3D mucosal model development, an overview, Tesolin, L. , ECR Trimestrial meeting Inno4vac, virtual, 17/06/2024, virtual, (2024)
What qualification work is needed for 3D mucosal models for vaccine development, Tesolin, L. , A regulatory exchange on model characterization and qualification of 3D mucosal models for vaccine development , 06/06/2024, Issue RIVM, Bilthoven, The Netherlands, (2024)
WHO Guidelines on Post Approval Changes- Appendix 1 Reporting categories and suggested review timelines, Tesolin, L. , Workshop on management of post approval changes, 03-05/12/2024, Hanoi -Viet Nam, 05/12/2024, Hanoi, Viet Nam, (2024)
WHO Guidelines on Post approval Changes- Appendix 2+3 Reporting procedures and data requirements for quality changes to antigens + finished products, Tesolin, L. , Workshop on management of post approval changes, 03-05/12/2024, Hanoi -Viet Nam , 04/12/2024, Hanoi, Viet Nam, (2024)
2023
Comment implémenter l'analyse de tendance, Tesolin, L., and Auquier J. , Webinar ARP Senegal, 12/09/2023, Sciensano, Brussels, (2023)
Development of a multiplex-based immunoassay for the characterization of diphtheria, tetanus and acellular pertussis antigens in human combined DTaP vaccines., Vermeulen, Maxime, Feck Isabelle, Francotte Antoine, Hassall Laura, Tesolin L., Van Molle Wim, Pizzato Romain, Laurent Thierry, Hoebreck Charline, Stickings Paul, et al. , J Immunol Methods, 2023 Jun, Volume 517, (2023)
EU batch release procedure: Annual Report 2 - Batch Release of Vaccines, Waeterloos, Geneviève, Auquier J., Domicent C., Cuignet L., Clouet S., Desmet N., Florens Morgane, Laurent F., Masquelier F., Ribaucour F, et al. , 2023 05 25, p.314, (2023)
l'analyse de tendance-concepts préliminaires, Tesolin, L., and Desmet N. , webinar ARP Senegal, 12/09/2023, Sciensano, Brussels, (2023)
OCABR: Respiratory Syncytial Virus (rDNA) Vaccine, Tesolin, L., Garcia D., Oppling V., Bruysters M., Pullirsch D., and Campitelli L. , 29/09/2023, Strasbourg (F), p.15, (2023)
Phase 2 testing: where are we now?, Bruysters, M., Tesolin L., and Lange J. , OMCL Annual Meeting EDQM 2023, 06/2023, Madrid, SPain, (2023)
Rational arguments for regulatory acceptance of consistency testing: benefits of non-animal testing over release testing of vaccines., Hoefnagel, Marcel H. N., Stickings Paul, Smith Dean, Jungbäck Carmen, Van Molle Wim, and Tesolin L. , Expert Rev Vaccines, 2023 Apr 03, Volume 22, Issue 1, Number 377, (2023)
Report of WHO Drafting Group meeting to revise WHO Guidelines on procedures and data requirements for changes to approved vaccines, Tesolin, L., Meyer H., Lei D., Jivapaisarnpong T., Welin M., and Cheung A. , 10/10/2023, Geneva, switzerland, p.9, (2023)
A roadmap for regulatory implementation of in vitro models for evaluation of vaccine efficacy, Vandebriel, R. J., Tesolin L., Veenstra K., and Huber K. , 08/2023, Niagara falls, Canada, (2023)
Training on the assessment of quality part (M3) of the eCTD for the registration of vaccines for human use, Brusselmans, Koen, Van Molle Wim, and Tesolin L. , Training on The assessment of quality part (M3) of the eCTD for the registration of vaccines for human use, 15/11/2023, Brussels, Belgium, (2023)
The vaccine Batch release procedure in Europe, Tesolin, L. , Seminaire etudiants en pharmacie ULB, 04/12/2023, Brussels, Belgium, (2023)
WHO Drafting Group meeting to revise WHO Guidelines on PAC- outcome of workshops, Tesolin, L. , WHO Drafting Group meeting to revise WHO Guidelines on procedures and data requirements for changes to approved vaccines, 20/09/2023, Frankfurt, Germany, (2023)
2022
Auditors experience with remote audits:Preparatory phase, Waeterloos, Geneviève, Tesolin L., and Van Molle Wim , OMCL annual meeting 2022, 14/06/2022, EDQM, strasbourg, (2022)
The batch release procedure in Europe, Tesolin, L. , Seminaire etudiants en pharmacie ULB, 05/12/2022, Brussels, Belgium, (2022)

QR code

QR code for this page URL